GS PHARMA
Board
1 director, since incorporationManager, permanent representative
appointed by deed of 06-09-2012
term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 20-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 24-05-2023
Permanent representatives 1
Mandates through the years
1 name, the dashed line is todayManager
Board
Mandates as a list
-
- Manager, appointed by deed of 06-09-2012, still in office
Control
Parent
Equity €1.8m
Profit €34,066 in 2024 (profit €41,833 in 2023)
Source: accounts 31-03-2024
100%
This company
GS PHARMA
Equity €148,356
Profit €124,005 in 2025
Capital
- Contribution
- €20,000
- Shares
- 1,000
- Contribution per share
- €20
- Equity per share
- €148 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 24-05-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of May at 20:00
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 24-05-2023 ↗
- all shares
At incorporation
deed of 06-09-2012 ↗
- 300 shares (30%) · €6,000
- 700 shares (70%) · €14,000
Capital over time
- 24-05-2023 Converted to unavailable equity
- 06-09-2012 Incorporation · €20,000 · 1,000 shares